Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Funingkang Jiaonang (妇宁康胶囊) is a traditional Chinese medicine (TCM) oral capsule developed and manufactured by Sichuan Senke Pharmaceutical (marketed under the Senkeyuan brand). It is a multi-herb formulation typically containing ingredients such as *Leonurus japonicus*, *Angelica sinensis*, and *Corydalis yanhusuo*. The drug is indicated for gynecological conditions characterized by Qi stagnation and blood stasis, specifically irregular menstruation and dysmenorrhea. It functions by promoting blood circulation, regulating Qi, and relieving pain. As a TCM product, it is approved for marketing in China and is included in various national drug catalogs, including the National Essential Drugs and Medical Insurance lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Funingkang Jiaonang.